|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.22 USD | -1.56% |
|
+4.00% | +11.35% |
| 12-08 | Carlyle Leads Bidding for Japan's Hogy Medical | MT |
| 12-08 | Iraq restores West Qurna 2 output after brief outage, sources say | RE |
| Capitalization | 20.26B 17.44B 16.37B 15.22B 28.06B 1,827B 30.61B 191B 73.88B 862B 76.05B 74.42B 3,160B | P/E ratio 2025 * |
13.5x | P/E ratio 2026 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise value | 20.79B 17.9B 16.8B 15.62B 28.79B 1,875B 31.41B 196B 75.82B 885B 78.04B 76.37B 3,243B | EV / Sales 2025 * |
5.34x | EV / Sales 2026 * | 4.09x |
| Free-Float |
72.3% | Yield 2025 * |
2.49% | Yield 2026 * | 2.63% |
Last Transcript: The Carlyle Group Inc.
| 1 day | -1.56% | ||
| 1 week | +4.00% | ||
| Current month | +3.10% | ||
| 1 month | +7.23% | ||
| 3 months | -12.36% | ||
| 6 months | +21.48% | ||
| Current year | +11.35% |
| 1 week | 54.18 | 57.59 | |
| 1 month | 50.42 | 57.59 | |
| Current year | 33.02 | 69.85 | |
| 1 year | 33.02 | 69.85 | |
| 3 years | 25.2 | 69.85 | |
| 5 years | 24.59 | 69.85 | |
| 10 years | 11.25 | 69.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harvey Schwartz
CEO | Chief Executive Officer | 61 | 14/02/2023 |
John Redett
DFI | Director of Finance/CFO | 57 | 30/09/2023 |
Lúcia Soares
CTO | Chief Tech/Sci/R&D Officer | 51 | 17/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
William Conway
CHM | Chairman | 75 | 24/10/2017 |
Daniel D'Aniello
CHM | Chairman | 78 | 31/12/1986 |
David Rubenstein
CHM | Chairman | 75 | 24/10/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.56% | +4.00% | +6.38% | +93.06% | 20.26B | ||
| -0.51% | +3.43% | -19.05% | +91.49% | 118B | ||
| +0.63% | +6.59% | -17.57% | +169.82% | 116B | ||
| -0.73% | +2.98% | -7.76% | +134.12% | 36.19B | ||
| +0.74% | -0.22% | +5.24% | +26.36% | 16.17B | ||
| 0.00% | +2.14% | -5.36% | +10.86% | 15.04B | ||
| +0.27% | -1.60% | +14.45% | +127.02% | 12.12B | ||
| -1.20% | +2.57% | +5.47% | -13.96% | 12.04B | ||
| -1.35% | +6.59% | -32.12% | +42.78% | 10.65B | ||
| -9.71% | -8.00% | +39.39% | +73.58% | 10.62B | ||
| Average | -1.44% | +2.64% | -1.09% | +75.51% | 36.77B | |
| Weighted average by Cap. | -0.47% | +3.99% | -11.23% | +110.13% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.89B 3.35B 3.15B 2.93B 5.39B 351B 5.88B 36.67B 14.2B 166B 14.62B 14.3B 607B | 4.81B 4.14B 3.89B 3.61B 6.66B 433B 7.26B 45.27B 17.53B 205B 18.04B 17.66B 750B |
| Net income | 1.49B 1.28B 1.21B 1.12B 2.07B 135B 2.25B 14.05B 5.44B 63.51B 5.6B 5.48B 233B | 1.76B 1.52B 1.42B 1.32B 2.44B 159B 2.66B 16.58B 6.42B 74.96B 6.61B 6.47B 275B |
| Net Debt | 531M 457M 429M 399M 735M 47.88B 802M 5B 1.94B 22.61B 1.99B 1.95B 82.83B | -612M -527M -495M -460M -847M -55.17B -924M -5.76B -2.23B -26.05B -2.3B -2.25B -95.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/12/25 | 56.22 $ | -1.56% | 2,302,395 |
| 05/12/25 | 57.11 $ | +1.44% | 2,496,765 |
| 04/12/25 | 56.30 $ | +0.91% | 2,792,446 |
| 03/12/25 | 55.79 $ | +3.24% | 1,446,203 |
| 02/12/25 | 54.04 $ | -0.04% | 1,810,570 |
Delayed Quote Nasdaq, December 08, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















